Check out this podcast— Founder and Executive Director of the Multidisciplinary Association for Psychedelic Studies Rick Doblin discusses the role of MDMA-guided psychotherapy in treating PTSD.
Rick shares the story of how he developed a passion for healing the brain with psychedelics and the 35-year journey he’s endured to build a growing non-profit organization. He also explains how to effectively work with drugs that have been aggressively stigmatized and politicized.
Read more
Upon the FDA approval of psychedelic medicine for psychiatric indications—such as MDMA for post-traumatic stress disorder or psilocybin for depression—psychiatric pharmacists in particular and all pharmacists generally, will play a pivotal role in the psychedelic medicine market in the US.
Read more
Michael Pollan looks at the legalization of some psychedelics and asks how should we do drugs now?
Read more
Psychedelic users say that even bad trips gave them ‘life-altering insights’, a small study finds.
Read more
Psychedelics are promising treatments for mental illness. Dozens of new startups have sprung up to develop and deliver the drugs to patients in need.
Read more
Research is the emerging psychedelics framework.
Read more
Why does nature produce hallucinogenic compounds? One study set out to uncover the answer... keep reading to find out more.
Read more
Check out this Q&A with Beckley Psytech Director & Chair of Scientific Advisory Board, Lady Amanda Feilding.
Amanda Feilding has been called the ‘hidden hand’ behind the renaissance of psychedelic science. Her contribution to global drug policy reform and to opening the doors to scientific research has been pivotal and widely acknowledged.
Read more